Abiopharma

IN8bio Presents Updated Overall Survival Data Surpassing 19.5 Months for DeltEx DRI in Newly Diagnosed Glioblastoma at ASCO 2026

JET.AI ANNOUNCES LEADING INDEPENDENT PROXY ADVISORY FIRM GLASS LEWIS RECOMMENDS STOCKHOLDERS VOTE “FOR” THE PROPOSED MERGER

PolyPid Completes New Drug Application Submission to FDA for D-PLEX₁₀₀

Celcuity to Hold Conference Call to Discuss Results for the PIK3CA Mutant Cohort of the Phase 3 VIKTORIA-1 Clinical Trial of Gedatolisib Regimens in HR+/HER- Advanced Breast Cancer on June 2, 2026

Tempus Announces the Upcoming Clinical Availability of Its First Whole-Genome Sequencing Assay, xH

Cosmos Health Enters $69 Billion Global Animal Health Industry with Veterinary C-Scrub Wash 4% Following Successful European Standard Testing Under EN 1656 and EN 1657

Janus Living Announces Launch of Public Offering of Class A-1 Common Stock

NiCE World 2026: taking place on June 8-10th - Where Agentic AI Meets Enterprise Scale-PR

Vaxart Files Definitive Proxy Statement and Mails Letter to Shareholders

Greenwich LifeSciences Presents FLAMINGO-01 Phase III Trial Open Label Data Published at ASCO Meeting 2026